|
Class 2 Device Recall Nova Biomedical |
|
Date Initiated by Firm |
March 30, 2004 |
Date Posted |
July 20, 2004 |
Recall Status1 |
Terminated 3 on June 17, 2004 |
Recall Number |
Z-0827-04 |
Recall Event ID |
28725 |
Product Classification |
Electrode Measurement, Blood-Gases (Pco2, Po2) And Blood Ph - Product Code CHL
|
Product |
Stat Profile Critical Care Xpress CCX+ Analyzer Catalog Number: 37413 |
Code Information |
Domestic Serial Numbers: Y02C03170 Y02C03140 Y02C03180 Y02104060 Y02104180 Y02104070 Y02104210 Y02104080 Y02204180 International S/N: Y02204030 Y02204040 Y02204050 Y02204110 Y02204120 Y02204140 Y02204190 Y02304020 Y02C03190 Y02C03160 Y02C03090 Y02204060 Y02C03070 Y02304050 Y02C03050 Y02104090 Y02104230 Y02104170 Y02104020 Y02304070 |
Recalling Firm/ Manufacturer |
Nova Biomedical Corporation 200 Prospect St Waltham MA 02453-3457
|
For Additional Information Contact |
Paul MacDonald 781-647-3700 Ext. 211
|
Manufacturer Reason for Recall |
Incorrectly assembled pumps may result in inconsistent compression of the tubing causing erratic results or calibration problems
|
FDA Determined Cause 2 |
Other |
Action |
Nova Biomedical notified users by telephone on 3/31/04 and conducted follow-up by letter either by email or fax. On-site visit will be scheduled to replace the pump assembly. |
Quantity in Commerce |
30 units |
Distribution |
CA, IL, LA, MA ,NJ, NY, OH, PA, TX
International: Italy ,England, Japan,Turkey., U.A.E., Greece, Thailand, Switzerland, Finland, Saudi Arabia, Italy, Mexico, Trinidad, Ireland, France, Cyprus, Czech Republic, ,Germany |
Total Product Life Cycle |
TPLC Device Report
|
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
|
|
|